GlaxoSmithKline PLC Common Stoc
(NYSE: GSK) After Hours: 37.7747 
-0.05 (-0.12%) 4:12pm ET
-0.05 (-0.12%) 4:12pm ET| Last Trade: | 37.82 |
|---|---|
| Trade Time: | Mar 12 |
| Change: | 0.02 (0.05%) |
| Prev Close: | 37.84 |
| Open: | 37.88 |
| Bid: | N/A |
| Ask: | N/A |
| 1y Target Est: | 42.06 |
| Day's Range: | 37.68 - 37.95 |
|---|---|
| 52wk Range: | 28.50 - 43.47 |
| Volume: | 1,325,253 |
| Avg Vol (3m): | 1,896,310 |
| Market Cap: | 95.93B |
| P/E (ttm): | 11.50 |
| EPS (ttm): | 3.29 |
| Div & Yield: | 2.29 (6.10%) |
News
- Abbott's TriCor Fails To Beat A Sugar Pill (at Forbes.com)
- 5 Stocks That Laugh at Wall Street (at Motley Fool)
- Ligand, Glaxo drug gets European approval (AP)
- GlaxoSmithKline makes vaccine executive changes (AP)
- FDA Still Has a Bone to Pick With These Drugmakers (at Motley Fool)
- Synta swings to profit on GSK breakup (at bizjournals.com)
- The Next Big Opportunity for Big Pharma Is BRIC (at Minyanville.com)
[+] View All
Today's Hot Topics
Editor's Picks
- My Secret to Lasting Dividend Income
- Inside the Numbers: Profiting from the 'Short Squeeze'
- A Fashionable Play Could Lead to a +38% Gain
- Advice I'd Only Share with Fabulously Rich Friends
- Invest Like Buffett With This 'Free Money' Company
- The Only Company Left Standing in a $40 Billion Battle
- This Commodity is Ready to Rocket
[+]View More
Meet Amy Calistri -- Editor of StreetAuthority's Stock of the Month
Biofuel Timetable Spells +15,900% Growth
Breakthrough "Oxy-Coal" Discovery
These Health-Care Providers Are Immune To Economic Downturns
